Annual EBITDA
-$20.91 M
-$2.39 M-12.88%
December 31, 2023
Summary
- As of February 7, 2025, NSPR annual EBITDA is -$20.91 million, with the most recent change of -$2.39 million (-12.88%) on December 31, 2023.
- During the last 3 years, NSPR annual EBITDA has fallen by -$10.68 million (-104.43%).
- NSPR annual EBITDA is now -550189.47% below its all-time high of -$3800.00, reached on June 30, 2009.
Performance
NSPR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$8.39 M
-$198.00 K-2.42%
September 30, 2024
Summary
- As of February 7, 2025, NSPR quarterly EBITDA is -$8.39 million, with the most recent change of -$198.00 thousand (-2.42%) on September 30, 2024.
- Over the past year, NSPR quarterly EBITDA has dropped by -$2.81 million (-50.37%).
- NSPR quarterly EBITDA is now -127251.52% below its all-time high of $6600.00, reached on September 30, 2009.
Performance
NSPR Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$29.68 M
-$2.81 M-10.46%
September 30, 2024
Summary
- As of February 7, 2025, NSPR TTM EBITDA is -$29.68 million, with the most recent change of -$2.81 million (-10.46%) on September 30, 2024.
- Over the past year, NSPR TTM EBITDA has dropped by -$9.63 million (-48.05%).
- NSPR TTM EBITDA is now -471179.37% below its all-time high of $6300.00, reached on September 30, 2009.
Performance
NSPR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NSPR EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.9% | -50.4% | -48.0% |
| 3 y3 years | -104.4% | -110.1% | -106.8% |
| 5 y5 years | -180.3% | -248.4% | -237.4% |
NSPR EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -43.7% | at low | -115.7% | at low | -103.9% | at low |
| 5 y | 5-year | -116.5% | at low | -326.0% | at low | -247.8% | at low |
| alltime | all time | <-9999.0% | +15.6% | <-9999.0% | +40.3% | <-9999.0% | at low |
InspireMD EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$8.39 M(+2.4%) | -$29.68 M(+10.5%) |
| Jun 2024 | - | -$8.19 M(+11.6%) | -$26.87 M(+12.3%) |
| Mar 2024 | - | -$7.34 M(+27.8%) | -$23.93 M(+14.4%) |
| Dec 2023 | -$20.91 M(+12.9%) | -$5.75 M(+3.0%) | -$20.91 M(+4.3%) |
| Sep 2023 | - | -$5.58 M(+6.2%) | -$20.05 M(+5.4%) |
| Jun 2023 | - | -$5.26 M(+21.5%) | -$19.02 M(+3.4%) |
| Mar 2023 | - | -$4.33 M(-11.4%) | -$18.41 M(-0.6%) |
| Dec 2022 | -$18.52 M(+27.3%) | -$4.88 M(+7.1%) | -$18.52 M(+5.7%) |
| Sep 2022 | - | -$4.56 M(-1.7%) | -$17.53 M(+3.3%) |
| Jun 2022 | - | -$4.64 M(+4.3%) | -$16.97 M(+7.8%) |
| Mar 2022 | - | -$4.45 M(+14.2%) | -$15.74 M(+8.1%) |
| Dec 2021 | -$14.55 M(+42.3%) | -$3.89 M(-2.6%) | -$14.55 M(+1.4%) |
| Sep 2021 | - | -$3.99 M(+17.2%) | -$14.35 M(+14.6%) |
| Jun 2021 | - | -$3.41 M(+4.4%) | -$12.52 M(+8.7%) |
| Mar 2021 | - | -$3.26 M(-11.5%) | -$11.52 M(+12.6%) |
| Dec 2020 | -$10.23 M(+5.9%) | -$3.69 M(+70.7%) | -$10.23 M(+13.6%) |
| Sep 2020 | - | -$2.16 M(-10.3%) | -$9.00 M(+2.3%) |
| Jun 2020 | - | -$2.41 M(+22.3%) | -$8.80 M(+3.1%) |
| Mar 2020 | - | -$1.97 M(-20.0%) | -$8.53 M(-11.6%) |
| Dec 2019 | -$9.66 M(+29.5%) | -$2.46 M(+25.9%) | -$9.66 M(+3.1%) |
| Sep 2019 | - | -$1.96 M(-8.8%) | -$9.37 M(+0.1%) |
| Jun 2019 | - | -$2.15 M(-30.7%) | -$9.35 M(+8.2%) |
| Mar 2019 | - | -$3.10 M(+42.7%) | -$8.64 M(+15.9%) |
| Dec 2018 | -$7.46 M(-8.1%) | -$2.17 M(+11.6%) | -$7.46 M(+11.1%) |
| Sep 2018 | - | -$1.94 M(+35.4%) | -$6.71 M(-1.5%) |
| Jun 2018 | - | -$1.44 M(-24.9%) | -$6.81 M(-10.7%) |
| Mar 2018 | - | -$1.91 M(+34.5%) | -$7.63 M(-6.0%) |
| Dec 2017 | -$8.11 M(+7.5%) | -$1.42 M(-30.4%) | -$8.11 M(-7.3%) |
| Sep 2017 | - | -$2.04 M(-9.3%) | -$8.76 M(+3.5%) |
| Jun 2017 | - | -$2.25 M(-6.0%) | -$8.46 M(+6.8%) |
| Mar 2017 | - | -$2.40 M(+16.2%) | -$7.92 M(+4.9%) |
| Dec 2016 | -$7.55 M | -$2.06 M(+17.9%) | -$7.55 M(-6.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | -$1.75 M(+2.3%) | -$8.08 M(-16.4%) |
| Jun 2016 | - | -$1.71 M(-15.5%) | -$9.66 M(-16.1%) |
| Mar 2016 | - | -$2.02 M(-21.9%) | -$11.51 M(-19.5%) |
| Dec 2015 | -$14.30 M(-38.9%) | -$2.59 M(-22.3%) | -$14.30 M(-11.0%) |
| Sep 2015 | - | -$3.33 M(-6.4%) | -$16.07 M(-15.9%) |
| Jun 2015 | - | -$3.56 M(-26.1%) | -$19.12 M(-15.8%) |
| Mar 2015 | - | -$4.82 M(+10.5%) | -$22.69 M(-3.1%) |
| Dec 2014 | -$23.41 M(+161.8%) | -$4.36 M(-31.6%) | -$23.41 M(+22.9%) |
| Sep 2014 | - | -$6.37 M(-10.7%) | -$19.05 M(+15.5%) |
| Jun 2014 | - | -$7.13 M(+28.8%) | -$16.49 M(-29.6%) |
| Mar 2014 | - | -$5.54 M(+45.2%) | -$23.42 M(-7.6%) |
| Dec 2013 | -$8.94 M(-63.9%) | - | - |
| Sep 2013 | - | -$3.81 M(-72.9%) | -$25.34 M(+2.3%) |
| Jun 2013 | - | -$14.06 M(+345.0%) | -$24.78 M(+131.2%) |
| Jun 2013 | -$24.77 M(+296.4%) | - | - |
| Mar 2013 | - | -$3.16 M(-26.6%) | -$10.72 M(+0.6%) |
| Dec 2012 | - | -$4.30 M(+32.4%) | -$10.65 M(-25.2%) |
| Sep 2012 | - | -$3.25 M(+5.2%) | -$14.25 M(-6.8%) |
| Jun 2012 | -$6.25 M(-53.2%) | - | - |
| Mar 2012 | - | -$3.09 M(-60.9%) | -$15.29 M(+14.6%) |
| Dec 2011 | -$13.34 M(>+9900.0%) | -$7.90 M(+269.9%) | -$13.34 M(+145.1%) |
| Sep 2011 | - | -$2.14 M(-1.1%) | -$5.44 M(+64.8%) |
| Jun 2011 | - | -$2.16 M(+88.6%) | -$3.30 M(+188.3%) |
| Mar 2011 | - | -$1.15 M(>+9900.0%) | -$1.15 M(>+9900.0%) |
| Dec 2010 | - | -$2600.00(-152.0%) | -$3800.00(-2.6%) |
| Sep 2010 | - | $5000.00(-308.3%) | -$3900.00(+69.6%) |
| Jun 2010 | -$15.50 K(+307.9%) | -$2400.00(-36.8%) | -$2300.00(+2200.0%) |
| Mar 2010 | - | -$3800.00(+40.7%) | -$100.00(-102.8%) |
| Dec 2009 | - | -$2700.00(-140.9%) | $3600.00(-42.9%) |
| Sep 2009 | - | $6600.00(-3400.0%) | $6300.00(-2200.0%) |
| Jun 2009 | -$3800.00 | -$200.00(+100.0%) | -$300.00(+200.0%) |
| Mar 2009 | - | -$100.00 | -$100.00 |
FAQ
- What is InspireMD annual EBITDA?
- What is the all time high annual EBITDA for InspireMD?
- What is InspireMD annual EBITDA year-on-year change?
- What is InspireMD quarterly EBITDA?
- What is the all time high quarterly EBITDA for InspireMD?
- What is InspireMD quarterly EBITDA year-on-year change?
- What is InspireMD TTM EBITDA?
- What is the all time high TTM EBITDA for InspireMD?
- What is InspireMD TTM EBITDA year-on-year change?
What is InspireMD annual EBITDA?
The current annual EBITDA of NSPR is -$20.91 M
What is the all time high annual EBITDA for InspireMD?
InspireMD all-time high annual EBITDA is -$3800.00
What is InspireMD annual EBITDA year-on-year change?
Over the past year, NSPR annual EBITDA has changed by -$2.39 M (-12.88%)
What is InspireMD quarterly EBITDA?
The current quarterly EBITDA of NSPR is -$8.39 M
What is the all time high quarterly EBITDA for InspireMD?
InspireMD all-time high quarterly EBITDA is $6600.00
What is InspireMD quarterly EBITDA year-on-year change?
Over the past year, NSPR quarterly EBITDA has changed by -$2.81 M (-50.37%)
What is InspireMD TTM EBITDA?
The current TTM EBITDA of NSPR is -$29.68 M
What is the all time high TTM EBITDA for InspireMD?
InspireMD all-time high TTM EBITDA is $6300.00
What is InspireMD TTM EBITDA year-on-year change?
Over the past year, NSPR TTM EBITDA has changed by -$9.63 M (-48.05%)